PlainPharmaWatch

CMS Open Payments · Program Year 2024

Sight Sciences, Inc.

Sight Sciences, Inc. reported $1,325,052.11 in payments to 7,583 physicians and teaching hospitals across 7,633 transactions.

See the rankings → How this is sourced
$1.3M
Total payments
7,633
Transactions
7,583
Recipients
−$262.1K
General Payments vs PY2023

Sight Sciences, Inc. reported $1,325,052.11 in payments to 7,583 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #556 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $174.74 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Sight Sciences, Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#556
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Sight Sciences, Inc.'s CMS-reported General Payments decreased by $262.1K (−20.5%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: SIGHT SCIENCES, INC.PY2023: SIGHT SCIENCES, INC.PY2024: Sight Sciences, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.3MPY2024$1.0M
PY2023
$1,279,443.21
PY2024
$1,017,351.71

How Sight Sciences, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Sight Sciences, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,325,052 Top 29% higher than 71% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Sight Sciences, Inc.

Rank #556 of 1,925 companies in CMS Open Payments for 2024 belongs to Sight Sciences, Inc., which reported $1,325,052.11 across 7,633 transactions to 7,583 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $173.60 per transaction and $174.74 per recipient.

285 transactions worth $524.5K make "Compensation for Services Other Than Consulting" the top general-payment category in the 7-category breakdown below, 39.6% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 7 types of general payments, Sight Sciences, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $524.5K - 39.6% of the company's reported total.

How Sight Sciences, Inc. divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$524.5K2. Food and Beverage$381.3K3. Consulting Fee$60.9K4. Grant$25.0K5. Travel and Lodging$17.7K6. Compensation for Faculty …$4.5K7. Honoraria$3.5K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $524.5K 285
Food and Beverage $381.3K 7,190
Consulting Fee $60.9K 41
Grant $25.0K 4
Travel and Lodging $17.7K 60
Compensation for Faculty or Speaker (Medical Education) $4.5K 2
Honoraria $3.5K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $139,035.75 (13.7%) of $1,017,351.71 in this company's General Payments records across 3,695 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Sight Sciences, Inc.

The five named recipients with the highest reported General Payments from this company

Thomas Michael Chester Jr.$39.1KMatthew James Antony Brink$30.6KPreeya Kshettry Gupta$25.0KNathan M Radcliffe$23.4KFelise May Galano Barte$20.9K
  1. 1

    Thomas Michael Chester Jr.

    $39,091.12 across 27 reported transactions

  2. 2

    Matthew James Antony Brink

    $30,613.95 across 28 reported transactions

  3. 3

    Preeya Kshettry Gupta

    $25,018.76 across 6 reported transactions

  4. 4

    Nathan M Radcliffe

    $23,365.67 across 19 reported transactions

  5. 5

    Felise May Galano Barte

    $20,946.25 across 26 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $173.60. Average per recipient: $174.74.

Total Amount

$1,325,052.11

Avg per Transaction

$173.60

Avg per Recipient

$174.74

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Sight Sciences, Inc. Share

0.0%

#556 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Sight Sciences, Inc.

Ironshore Pharmaceuticals Inc.

$1.3M 45,495 recipients

Spinal Elements, Inc.

$1.3M 850 recipients

Mayne Pharma Commercial LLC

$1.3M 29,072 recipients

Erbe Elektromedizin GmbH

$1.3M 3 recipients

Endolumik, Inc.

$1.3M 20 recipients

C. R. Bard, Inc. & Subsidiaries

$1.3M 2,216 recipients

Frequently Asked Questions

How much did Sight Sciences, Inc. pay to physicians and hospitals in 2024? ▾
Sight Sciences, Inc. made $1,325,052.11 in payments to physicians and hospitals in Program Year 2024, across 7,633 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Sight Sciences, Inc.? ▾
7,583 physicians and teaching hospitals received payments from Sight Sciences, Inc. in 2024, averaging $174.74 per recipient.
What types of payments did Sight Sciences, Inc. make? ▾
Sight Sciences, Inc. made 7 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $524.5K, representing 39.6% of the company's reported total.
How does Sight Sciences, Inc. rank among pharmaceutical companies? ▾
Sight Sciences, Inc. ranks #556 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Sight Sciences, Inc.? ▾
Sight Sciences, Inc.'s 7,633 transactions to 7,583 recipients in 2024 averaged $173.60 per transaction.
Where does the payment data for Sight Sciences, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Sight Sciences, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.